Emmanuelle Schuler

Dr. Schuler is passionate about bettering the lives of patients by impacting healthcare delivery through therapeutic innovation. She has over 20 years of expertise in strategic alliances, joint ventures, and intellectual assets that have brought together entrepreneurs, inventors, and clinicians to reimagine medical breakthroughs. Prior to joining the founding team of Stellanova, Schuler has been a member of the founding team at several companies, including JLABS @ TMC, where she spearheaded successful site operations and business development, and Corallis Consulting which focused on improving therapeutic solutions in conjunction with publicly traded companies based in the United States and Europe. Dr. Schuler holds a B.Sc. in Chemistry from Université du Québec à Montréal, a Ph.D. in Chemistry from McGill University followed by a post-doc with Chemistry Nobel Laureate Rick Smalley, and an MBA in Business and Strategy from Rice University.